The tumor volume for both local and systemic injections has a similar range in control or anti-VEGF but the maximum number of CAR-T cells in the tumor is lower in the local injection compared to systemic one [see tumor volume and number of CAR-T cells in Fig. 8]. The gene discussed is VEGFA; the disease is neoplasm.